The once-a-month implantable NuvaRing device is considered one of the most effective available at preventing pregnancy. However, the convenience could come at a price as the vaginal ring has been linked to serious NuvaRing side effects like blood clots.
Now, the maker of the device is reporting that sales have dropped amid more than 1,000 injury lawsuits and trials scheduled to start this year.
Medication safety experts have warned that contraceptives like NuvaRing may have higher risks of blood clots than traditional birth control pills. Last year, both the British Medical Journal and New England Journal of Medicine published data showing vaginal ring contraceptives could relate to 2 12 to 3 times the risk of blood clots.
Unfortunately, the device has been used by millions of women as an alternative to taking a daily pill. And with marketing from drug maker Merck that NuvaRing contains lower hormone doses, women believed it was safer.
Already, more than 1,100 patients have filed a NuvaRing lawsuit alleging blood clot injuries like stroke, pulmonary embolism or deep vein thrombosis (DVT). With the volume of cases, they have been consolidated to a special federal court in Missouri.
U.S. District Judge Rodney Sippel, who is overseeing the litigation, recently scheduled the first trial to start in October.
Now, Merck’s latest financial records show that sales of NuvaRing devices dropped from $164 million at the end of 2012 to $151 million in the first quarter of 2013, a decline of 8%.
Lawyers are still helping women injured by NuvaRing file claims. If you or a loved one suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing, it is important to speak with a lawyer about your legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.
Contact us today for more information on the research, side effects and litigation news related to NuvaRing, or to speak with a lawyer.